4//SEC Filing
ROBIN SHERRINGTON 4
Accession 0001209191-22-048508
CIK 0001582313other
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 4:27 PM ET
Size
24.0 KB
Accession
0001209191-22-048508
Insider Transaction Report
Form 4
ROBIN SHERRINGTON
See Remarks
Transactions
- Tax Payment
Common Shares
2022-09-01$38.81/sh−6,121$237,556→ 60,675 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-09-01−50,000→ 0 totalExercise: $4.75Exp: 2028-03-11→ Common Shares (50,000 underlying) - Exercise/Conversion
Common Shares
2022-08-31$2.67/sh+17,488$46,693→ 34,720 total - Exercise/Conversion
Common Shares
2022-08-31$4.75/sh+5,000$23,750→ 39,720 total - Tax Payment
Common Shares
2022-08-31$37.86/sh−1,572$59,516→ 38,148 total - Exercise/Conversion
Stock Options (Right to Buy)
2022-08-31−17,488→ 0 totalExercise: $2.67Exp: 2022-12-31→ Common Shares (17,488 underlying) - Sale
Common Shares
2022-08-31$38.57/sh−21,352$823,547→ 16,796 total - Exercise/Conversion
Common Shares
2022-09-01$4.75/sh+50,000$237,500→ 66,796 total - Sale
Common Shares
2022-09-01$38.03/sh−35,103$1,334,967→ 25,572 total - Sale
Common Shares
2022-09-01$38.80/sh−8,776$340,509→ 16,796 total - Exercise/Conversion
Stock Options (Right to Buy)
2022-08-31−5,000→ 0 totalExercise: $4.75Exp: 2028-03-11→ Common Shares (5,000 underlying)
Footnotes (6)
- [F1]Represents the closing price of the Company's common shares on August 30, 2022 for purposes of net settlement calculations.
- [F2]The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.18 to $38.83, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F3]Represents the closing price of the Company's common shares on August 31, 2022 for purposes of net settlement calculations.
- [F4]The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $37.44 to $38.35, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F5]The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.73 to $38.88, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F6]The shares subject to the option are fully vested and exercisable.
Documents
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeother
Related Parties
1- filerCIK 0001619962
Filing Metadata
- Form type
- 4
- Filed
- Sep 1, 8:00 PM ET
- Accepted
- Sep 2, 4:27 PM ET
- Size
- 24.0 KB